Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7323

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structure of venlafaxine hydrochloride showing the arrangement of atoms including a cyclohexane ring, methoxyphenyl group, and dimethylamino group, labeled in a black-and-white line diagram.*

FDA Label Image

Image-02 (Image 02)

A scatter plot chart showing fold changes and 90% confidence intervals for venlafaxine and its metabolite ODV in special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender differences. The x-axis represents change relative to the reference value, with dots plotted to indicate Cmax and AUC values for the analytes under each condition.*

FDA Label Image

Image-03 (Image 03)

A scatter plot illustrating fold changes and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its metabolite ODV when administered with various interacting drugs. The x-axis represents change relative to the reference value, comparing effects of ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Image-04 (Image 04)

A forest plot depicting fold change and 90% confidence intervals for the pharmacokinetic parameters Cmax and AUC of various analytes related to different interacting drugs. The plot shows fold changes relative to a reference value with a horizontal axis ranging from 0 to 3, with points indicating the estimated fold change and error bars representing confidence intervals for each drug analyte combination.*

FDA Label Image

Label Image (Lbl500907323)

Venlafaxine Hydrochloride Extended Release 150 mg capsules bottle label. The label shows the product name, dosage form as extended release capsule, strength 150 mg, and contains 30 capsules. It is labeled by A-S Medication Solutions, Libertyville, Illinois 60048, with NDC 50090-7323.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.